logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
R

Rafael Rosell

dexeus university

94H-index
996Paper Count
4.7WCitation Count
Published Papers 272
Publication Date
logo
Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report
errLung Cancer
IF4.4
err2026-06-09
err0
errOAAI
errBeatriz García-Peláez; Núria Jordana-Ariza; Andrés Aguilar-Hernández; Roger Estrada-Tejedor; Marta Vives-Usano; Mónica Garzón-Ibáñez; Clara Mayo-de-las-Casas; Ruth Román; Rafael Rosell; Miguel Ángel Molina-Vila
errShare
errSave
Phase Ib of repotrectinib plus osimertinib in patients with EGFR–mutated advanced non–small cell lung cancer
errLung Cancer
IF4.4
err2026-05-19
err0
PREAI
errAndres Aguilar; Manuel Cobo; Antonio Calles; Aitor Azkarate; Maria Gonzalez-Cao; Miguel A. Molina-Vila; Rafael Rosell
errShare
errSave
Cetuximab co-treatment with KRAS G12C inhibitors fulzerasib and sotorasib in human KRAS G12C non-small cell lung cancer cells
errCell Death Discovery
IF7
err2026-03-05
err0
errOAAI
errDaniel Olmo-González; Mengxin Zhou; Nuno G. Oliveira; Fusheng Zhou; Feng Yan; Jèssica González; Kevin València-Clua; Miguel Angel Molina-Vila; Jordi Bertrán-Alamillo; Ana Giménez-Capitán; Jordi Codony-Servat; Rafael Rosell
errShare
errSave
Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial
errNature Communications
IF15.7
err2025-12-12
err0
errOAAI
errOscar Arrieta; Luis Lara-Mejía; Eduardo Rios-Garcia; Enrique Caballé-Perez; Luis Cabrera-Miranda; Maritza Ramos-Ramírez; David Dávila-Dupont; Andrés F. Cardona; Graciela Cruz-Rico; Jordi Remon; Alexandra Garcilazo-Reyes; Rafael Rosell
errShare
errSave
Repurposing risperidone as an anti-angiogenic agent for triple-negative breast cancer: a computational to in ovo investigation
errFrontiers in Oncology
IF3.3
err2025-10-28
err0
errOAAI
errAnisha Jain; Anil Kumar Belagal Motatis; Chandan Dharmashekar; Bhargav Shreevatsa; Siddesh VS; Monisha Srinivas; Sudhanva Muddenahalli Srinivasa; Ashwini P; M. N. Nagendra Prasad; Rafael Rosell; Jordi Codony-Servat; Shobith Rangappa; Muzaffar Iqbal; Kasim Sakran Abass; Raghavendra G. Amachawadi; Victor Stupin; Shiva Prasad Kollur; Chandan Shivamallu; Ekaterina Silina
errShare
errSave
\zaAlectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: Final overall survival analysis of the Phase III ALEX study
errAnnals of Oncology
IF65.4
err2025-10-17
err0
errOAAI
errS. Peters; R. Camidge; R. Dziadziuszko; S. Gadgeel; A.T. Shaw; D-W. Kim; M. Pérol; D.R. Rosell; P. Cheema; D.Wan-Teck Lim; J.J. Lin; N. Pavlakis; J.S. Ahn; L. Zhang; V. Henschel; A.A. Higgerson; V. McNally; I. Rooney; A. Scalori; V. Smoljanovic; T. Mok
errShare
errSave
Concerns about induction of autophagy: à propos of ibrilatazar
errLung Cancer
IF4.4
err2025-06-06
err0
PREAI
errRafael Rosell
errShare
errSave
Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial
errNATURE COMMUNICATIONS
IF15.7
err2025-05-16
err0
errOAAI
errArrieta, Oscar; Lara-Mejia, Luis; Rios-Garcia, Eduardo; Caballe-Perez, Enrique; Cabrera-Miranda, Luis; Ramos-Ramirez, Maritza; Davila-Dupont, David; Cardona, Andres F.; Cruz-Rico, Graciela; Remon, Jordi; Garcilazo-Reyes, Alexandra; Rosell, Rafael
errShare
errSave
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
errNATURE REVIEWS CLINICAL ONCOLOGY
IF82.2
err2025-01-06
err2
PREAI
errWang, Yibei; Safi, Mohammed; Hirsch, Fred R.; Lu, Shun; Peters, Solange; Govindan, Ramaswamy; Rosell, Rafael
errShare
errSave
Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050
errFUTURE ONCOLOGY
IF2.6
err2024-10-03
err1
errOAAI
errPu, Xingxiang; Li, Juan; Zhang, Bo; Zhang, Jinyao; Mok, Tony S.; Nakagawa, Kazuhiko; Rosell, Rafael; Cheng, Ying; Zhou, Xiangdong; Miglorino, Maria Rita; Niho, Seiji; Lee, Ki Hyeong; Corral, Jesus; Pluzanski, Adam; Li, Junling; Linke, Rolf; Pan, Fang; Tang, Yiyun; Tan, Weiwei; Wu, Lin
errShare
errSave
Impact of the redox-active MnTnHex-2-PyP5+5+and cisplatin on the metabolome of non-small cell lung cancer cells
errBIOCHEMICAL PHARMACOLOGY
IF5.6
err2024-09-01
err0
errOAAI
errSoares, Rita B.; Pinto, Joana; Amaro, Filipa; Manguinhas, Rita; Gil, Nuno; Rosell, Rafael; Batinic-Haberle, Ines; Fernandes, Ana S.; Oliveira, Nuno G.; de Pinho, Paula Guedes
errShare
errSave
A multicenter, retrospective study of non-small-cell lung carcinoma (NSCLC) harboring EGFR exon 20 insertions: Distribution, variants, and prevalence of coalterations
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errSullivan, I. G.; Garzon, M.; Malapelle, U.; de Oliveira Cavagna, R.; Aguilar Hernandez, A.; Valdivia, A. A.; Reyes Cabanillas, R. M.; Clave, S.; Saigi Morgui, M.; Sais, E.; Mosteiro Lamas, M. A.; Calabuig Farinas, S.; Barba Joaquin, A.; Fernandez Bruno, M.; Minatta, J. N.; Viteri, S.; Bluthgen, M. V.; Pandolfi, J.; Mayo de las Casas, C.; Rosell, R.
errShare
errSave
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
errLUNG CANCER-TARGETS AND THERAPY
IF3.3
err2024-06-01
err0
errOAAI
errOu, Sai-Hong Ignatius; Le, Xiuning; Nagasaka, Misako; Reungwetwattana, Thanyanan; Ahn, Myung-Ju; Lim, Darren W. T.; Santos, Edgardo S.; Shum, Elaine; Lau, Sally C. M.; Lee, Jii Bum; Calles, Antonio; Wu, Fengying; Lopes, Gilberto; Sriuranpong, Virote; Tanioki, Junko; Horinouchi, Hidehito; Garassino, Marina C.; Popat, Sanjay; Besse, Benjamin; Rosell, Rafael; Soo, Ross A.
errShare
errSave
Reply to Rio-Vilariño and colleagues' article and misconception about YAP1 Ser 397 phosphorylation function
errBRITISH JOURNAL OF CANCER
IF6.8
err2024-05-21
err1
PREAI
errRosell, Rafael
errShare
errSave
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer
errLUNG CANCER-TARGETS AND THERAPY
IF3.3
err2024-05-01
err0
errOAAI
errGonzalez-Cao, Maria; Cai, Xueting; Bracht, Jilian Wilhelmina Paulina; Han, Xuan; Yang, Yang; Pedraz-Valdunciel, Carlos; Moran, Teresa; Garcia-Corbacho, Javier; Aguilar, Andres; Bernabe, Reyes; De Marchi, Pedro; da Silva, Luciane Sussuchi; Leal, Leticia Ferro; Reis, Rui Manuel; Codony-Servat, Jordi; Jantus-Lewintre, Eloisa; Molina-Vila, Miguel Angel; Cao, Peng; Rosell, Rafael
errShare
errSave
Molecular characterization and drug sensitivity of a gastric FGFR2-TACC2 and a pancreatic KRAS p.G12C primary culture
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errGarcia-Roman, Silvia; Nikolaeva, Ekaterina Meshoulam; Mosquera, Juan Jose Garcia; Ibanez, Monica Garzon; Roman, Ruth; Rodriguez, Sonia; Rodriguez, Cristina; de las Casas, Clara Mayo; Rosell, Rafael; Molina-Vila, Miguel A.; Esteban, Cristina Aguado
errShare
errSave
Deterministic reprogramming and signaling activation following targeted therapy in non-small cell lung cancer driven by mutations or oncogenic fusions
errEXPERT OPINION ON INVESTIGATIONAL DRUGS
IF4.1
err2024-02-23
err2
PREAI
errRosell, Rafael; Pedraz-Valdunciel, Carlos; Jain, Anisha; Shivamallu, Chandan; Aguilar, Andres
errShare
errSave
Converging and evolving immuno-genomic routes toward immune escape in breast cancer
errNATURE COMMUNICATIONS
IF15.7
err2024-02-21
err3
errOAAI
errBlanco-Heredia, Juan; Souza, Carla Anjos; Trincado, Juan L.; Gonzalez-Cao, Maria; Goncalves-Ribeiro, Samuel; Gil, Sara Ruiz; Pravdyvets, Dmytro; Cedeno, Samandhy; Callari, Maurizio; Marra, Antonio; Gazzo, Andrea M.; Weigelt, Britta; Pareja, Fresia; Vougiouklakis, Theodore; Jungbluth, Achim A.; Rosell, Rafael; Brander, Christian; Tresserra, Francesc; Reis-Filho, Jorge S.; Tiezzi, Daniel Guimaraes; de la Iglesia, Nuria; Heyn, Holger; De Mattos-Arruda, Leticia
errShare
errSave
Pangaea Oncology, Dexeus University Hospital: bridging preclinical and clinical research
errMOLECULAR CANCER
IF33.9
err2024-01-25
err0
errOAAI
errGonzalez-Cao, Maria; Pedraz, Carlos; Molina-Vila, Miguel Angel; Rosell, Rafael
errShare
errSave
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
errBRITISH JOURNAL OF CANCER
IF6.8
err2023-12-14
err2
PREAI
errPostel-Vinay, Sophie; Coves, Juan; Texier, Matthieu; Aldea, Mihaela; Gazzah, Anas; Domine, Manuel; Planchard, David; De Las Penas, Ramon; Gonzalez, Ma Angeles Sala; Viteri, Santiago; Perez, Javier; Ortega, Ana Laura; Moran, Teresa; Camps, Carlos; Lopez-Martin, Ana; Provencio, Mariano; Soria, Jean-Charles; Besse, Benjamin; Massuti, Bartomeu; Rosell, Rafael
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Marc Ladanyi
H-index: 204 · Papers: 2.5K
J
Julian P. T. Higgins
H-index: 163 · Papers: 820
J
Jonathan S. Weissman
H-index: 157 · Papers: 550
J
Jorge S. Reis‐Filho
H-index: 153 · Papers: 1.5K
I
Ignacio I. Wistuba
H-index: 153 · Papers: 2.8K
View more